The Diagnostic Accuracy of the M2 Pyruvate Kinase Quick Stool Test- A Rapid Office Based Assay Test for the Detection of Colorectal Cancer

作者: Suresh Sithambaram , Ida Hilmi , Khean-Lee Goh

DOI: 10.1371/JOURNAL.PONE.0131616

关键词: Stool testGastroenterologyEsophageal cancerBreast cancerGastrointestinal diseaseColorectal cancerColonoscopyInternal medicinePoint of carePredictive value of testsMedicine

摘要: Background M2 pyruvate kinase (M2PK) is an oncoprotein secreted by colorectal cancers in stools. This the first report on accuracy of a rapid stool test detection cancer (CRC). Objective To determine sensitivity, specificity and positive negative predictive value rapid, point care M2 PK- M2PK Quick. Methods Consecutive cases endoscopically diagnosed histological proven CRC were recruited. Stools collected patients tested with immunochromatographic Quick Test (Schebo Biotech AC, Giessen, Germany). Controls consecutively chosen from without any significant or gastrointestinal disease undergoing colonoscopy. was staged according to AJCC staging manual (7th Edition) location tumor defined as proximal distal. Results The specificity, value, overall were: 93%, 97.5%, 94.9%, 96.5% 96.0% respectively. The for tumors significantly lower compared distal tumors. No differences seen between different stages tumor. Conclusions M2-PK Quick, point-of-care highly accurate CRC. It easy convenient perform useful diagnostic clinical practice setting.

参考文章(24)
Marcellus Simadibrata, Murdani Abdullah, Ari Fahrial Syam, Achmad Fauzi, Abdul Aziz Rani, The value of fecal tumor M2 pyruvate kinase as a diagnostic tool for colorectal cancer screening. Acta medica Indonesiana. ,vol. 44, pp. 94- 99 ,(2012)
Carolin Tonus, Colorectal cancer screening by non-invasive metabolic biomarker fecal tumor M2-PK World Journal of Gastroenterology. ,vol. 12, pp. 7007- 7011 ,(2006) , 10.3748/WJG.V12.I43.7007
T MORIKAWA, J KATO, Y YAMAJI, R WADA, T MITSUSHIMA, Y SHIRATORI, A Comparison of the Immunochemical Fecal Occult Blood Test and Total Colonoscopy in the Asymptomatic Population Gastroenterology. ,vol. 129, pp. 422- 428 ,(2005) , 10.1016/J.GASTRO.2005.05.056
Yogesh Kumar, Niteen Tapuria, Naveed Kirmani, Brian R Davidson, None, Tumour M2-pyruvate kinase: a gastrointestinal cancer marker European Journal of Gastroenterology & Hepatology. ,vol. 19, pp. 265- 276 ,(2007) , 10.1097/MEG.0B013E3280102F78
Zohar Levi, Paul Rozen, Rachel Hazazi, Alex Vilkin, Amal Waked, Eran Maoz, Shlomo Birkenfeld, Moshe Leshno, Yaron Niv, A quantitative immunochemical fecal occult blood test for colorectal neoplasia. Annals of Internal Medicine. ,vol. 146, pp. 244- 255 ,(2007) , 10.7326/0003-4819-146-4-200702200-00003
M Naumann, B Schaum, G M Oremek, E Hanisch, W Rösch, J Mössner, W F Caspary, J Stein, [Faecal pyruvate kinase type M2--a valid screening parameter for colorectal cancer? Preliminary results from a multicenter comparative study]. Deutsche Medizinische Wochenschrift. ,vol. 129, pp. 1806- 1807 ,(2004) , 10.1055/S-2004-829033
T Vogel, C Driemel, A Hauser, A Hansmann, S Lange, M Jonas, G Möslein, Vergleich verschiedener Stuhltests zur Detektion von Neoplasien des Kolon Deutsche Medizinische Wochenschrift. ,vol. 130, pp. 872- 877 ,(2005) , 10.1055/S-2005-865100
Ronan Leen, Chun Seng-Lee, Grainne Holleran, Colm O’Morain, Deirdre McNamara, Comparison of faecal M2-PK and FIT in a population-based bowel cancer screening cohort. European Journal of Gastroenterology & Hepatology. ,vol. 26, pp. 514- 518 ,(2014) , 10.1097/MEG.0000000000000025